At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.
OVERALL PURPOSE OF JOB: To maximize company product value through high scientific quality communication with Leading Specialists on a peer-to-peer basis. Accordingly, to strategic lines of Medical Affairs Plan, the MSL is jointly responsible for achieving short-term and long-term company goals at local level. To be a therapeutic area scientific expert, responsible for discussing our products, patients’ treatment trends and studies in the therapeutic areas in which we are involved, on a peer-to-peer basis with a defined audience of Leading Specialists (Physicians, Pharmacists, Hospital Managers, Board Members of Scientific Societies, and other stakeholders) and to be considered an internal and external trusted scientific counterpart. The Individual Activity Plans must be based on the MSLs Country Activity Plan, which is aligned with the Medical Affairs Component of the relevant Brand Plans To keep abreast of medical and scientific knowledge. Development and maintenance of a contact network with Leading Specialists. clinical questionnaire discussions Through scientific interactions, communicate medical benefits of products and contribute to foster innovative approaches Represent the company within professional associations in the therapeutic area in cooperation with Medical Affairs/ Medical Education and other positions in the Medical Affairs Department Proactive and reactive communication of medical scientific data according to following criteria: Content of Scientific Communication should be highly scientific, accurate, fair and objective,



based on an up-to-date evaluation of all relevant evidence and reflect that evidence clearly, using neither marketing claims nor brand name, for individual or groups of physicians (group calls) In some very specific circumstances, the MSL can interact proactively with non‑Leading Specialists. The program should be clearly defined in the MSL Country Activity Plan, providing the rational, the objective, content, timelines and selection criteria of the HCPs to be involved Description of R&D; programs and discussing regulatory developments with no promotional intent are also part of Scientific Communication. Reactive Communication of medical scientific data can be provided upon request to any Health Care Professional, within the approved label or off-label. Organization and participation in Medical Education activities, at local &/regional level: Market Access Discussions MSLs can present highly scientific, accurate, fair and objective data to Payors (Hospital Formulary Committees, Health Insurers, Health Technology Assessment Committees, etc) to provide them with objective information about Company products. Pre‑ Approval Activities MSLs can engage in interactions with Payors to raise awareness so that payors can plan and budget so that patients can receive the product when it becomes available. MSLs can organize Speakers training to prepare speakers for delivering presentations to other HCP when the Marketing Authorization is granted.



Provision of scientific support to company Sales Representatives and other company representatives Provide medical and product training and scientific support to Sales Representatives in coordination with Training/Medical Affairs Department as appropriate Act as a reference point to Sales Representatives for any scientific query, in collaboration with Medical Information as appropriate Local implementation of Medical Affairs Plan in their areas: Support the set up and follow up of local company sponsored studies, registries and other non-interventional Medical Affairs studies Propose investigators and sites for interventional and non-interventional Medical Affairs studies. Receive investigator proposals for IIS and ensure they are discussed within the Medical Affairs department for decision. Observes and promotes all regulatory requirements as defined in applicable regulations, rules and procedures established by the Company, including but not limited to Health Care Business Integrity and Pharmacovigilance Follow principles, procedures and training included in SAFE Fleet program. Report any AEs, PQCs and/or special situations to the local designated person (e.g., LSO/designee), local Call Center or electronic collection tool within one (1) Business Day. In the event of a public holiday, measures must be taken to ensure reporting no later than Calendar Day Three (3). Ensure inspection readiness with respect to individual personal training compliance, and availability of recent Summary of Experience (SOE) and individualized

Job Description
. Additionally, for all employees involved in Research Related Activities (RRA): Ensure safety reporting requirements (timely AE/PQC reporting) as set out in compan

📌 MSL Oncology (Madrid)
🏢 7300-Janssen-Cilag S.A. Legal Entity
📍 Madrid